HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

L A Wilson Selected Research

oxidized low density lipoprotein

2/2015NASH resolution is associated with improvements in HDL and triglyceride levels but not improvement in LDL or non-HDL-C levels.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


L A Wilson Research Topics

Disease

2Gastroparesis
01/2018 - 05/2013
1Cardiovascular Diseases (Cardiovascular Disease)
02/2015
1Dyslipidemias (Dyslipidemia)
02/2015
1Non-alcoholic Fatty Liver Disease
02/2015
1Abdominal Pain (Pain, Abdominal)
05/2013
1Nausea
05/2013
1Vomiting
05/2013
1Diabetic Neuropathies (Diabetic Neuropathy)
05/2013
1Pain (Aches)
05/2013
1Multiple Myeloma
05/2010
1Ischemic Stroke
01/2005
1Polyps
06/2001
1Leukemia
12/2000
1Neoplasms (Cancer)
12/2000
1Adult T-Cell Leukemia-Lymphoma (Leukemia Lymphoma, T Cell, Acute, HTLV I Associated)
12/2000
1Infections
08/2000
1Huntington Disease (Huntington's Disease)
07/2000

Drug/Important Bio-Agent (IBA)

1Capsules (Microcapsules)IBA
01/2018
1oxidized low density lipoproteinIBA
02/2015
1Pioglitazone (Actos)FDA Link
02/2015
1LipidsIBA
02/2015
1HDL LipoproteinsIBA
02/2015
1Triglycerides (Triacylglycerol)IBA
02/2015
1Vitamin EFDA LinkGeneric
02/2015
1Opiate AlkaloidsIBA
05/2013
1AntiemeticsIBA
05/2013
1Proteins (Proteins, Gene)FDA Link
05/2010
1Intravenous Immunoglobulins (IVIG)FDA Link
01/2005
1Contrast MediaIBA
06/2001
1Interleukin-2 (IL2)IBA
12/2000
1T-Cell Antigen Receptors (T-Cell Receptor)IBA
12/2000
1Interleukin-2 Receptor alpha SubunitIBA
12/2000
1Monoclonal AntibodiesIBA
12/2000
1ProgesteroneFDA LinkGeneric
08/2000
1Thymidine KinaseIBA
07/2000

Therapy/Procedure

1Therapeutics
12/2000